Prenatal testing for imprinting disorders: A laboratory perspective.

In summary, the decision for molecular prenatal testing for ImpDis should be based on close exchanges between clinicians, geneticists, and the families before the initiation of the test. These discussions should weigh the chances and challenges of the prenatal test, with focus on the need of the family. This article is protected by copyright. All rights reserved.